Audit Trails

Audit Trails in Clinical Trials: Ensuring Data Integrity, Transparency, and Compliance

Posted on digi By digi

In clinical trials, an audit trail is a secure, computer-generated, time-stamped electronic record that shows who accessed or modified data, what changes were made, when the changes occurred, and why they were made (when applicable). Audit trails support the traceability of clinical data and demonstrate that records are accurate, complete, and maintained in a manner compliant with Good Clinical Practice (GCP) and regulatory expectations like 21 CFR Part 11 and EMA Annex 11.
Click to read the full article.

Audit Trails, Data Integrity and ALCOA+ Principles

Understanding Audit Trails in EDC and eTMF Systems

Posted on digi By digi

Audit trails are the backbone of data integrity in clinical research. They provide the documented evidence of every action taken on a data element, from creation to modification to deletion. In systems like Electronic Data Capture (EDC) and Electronic Trial Master Files (eTMF), audit trails ensure compliance with ALCOA+ principles by recording who did what, when, and why.

Click to read the full article.

Audit Trails, Data Integrity and ALCOA+ Principles

What Regulators Expect in an Audit Trail Review

Posted on digi By digi

In recent years, both the FDA and EMA have intensified their focus on audit trail compliance during inspections. As clinical trials increasingly rely on electronic systems such as EDC, eTMF, eSource, and CTMS, the need for transparent, accurate, and tamper-proof audit trails has become non-negotiable. These records serve as the official “black box” of data events—detailing who did what, when, and why.

Click to read the full article.

Audit Trails, Data Integrity and ALCOA+ Principles

Common Audit Trail Findings in FDA Inspections

Posted on digi By digi

Audit trails are one of the most scrutinized components during FDA inspections of clinical trial systems. Whether it’s an Electronic Data Capture (EDC) platform, eTMF system, or laboratory database, regulators expect complete, accurate, and immutable audit logs. When these audit trails are missing, improperly configured, or not reviewed, it often results in formal inspection findings—including 483 observations and, in serious cases, warning letters.

Click to read the full article.

Audit Trails, Data Integrity and ALCOA+ Principles

Training Monitors to Review Audit Trail Data

Posted on digi By digi

Clinical Research Associates (CRAs), often referred to as monitors, serve as the frontline guardians of data quality and regulatory compliance in clinical trials. While much of their focus lies in source data verification and protocol adherence, a growing area of importance is their ability to review and interpret audit trail data—especially in electronic data capture (EDC), eSource, and eTMF systems.

Click to read the full article.

Audit Trails, Data Integrity and ALCOA+ Principles

Interpreting Audit Trails for Quality Control Reviews

Posted on digi By digi

In clinical research, audit trails are not only regulatory safeguards—they are powerful tools for quality control (QC) when properly interpreted. Quality control reviews serve to verify the integrity, completeness, and traceability of data, and audit logs offer an essential layer of visibility into how data is created, modified, and managed throughout the trial lifecycle.

Click to read the full article.

Audit Trails, Data Integrity and ALCOA+ Principles

eSource Audit Trails vs Paper Source Notes

Posted on digi By digi

Clinical trial documentation has evolved significantly over the past two decades. Traditional paper-based source notes are increasingly being replaced—or supplemented—by eSource systems such as ePRO, eCOA, wearable device data, or direct data entry into EDC. As sponsors and CROs transition toward digital platforms, questions arise about how audit trails in electronic systems compare to annotations and corrections in physical source records.

Click to read the full article.

Audit Trails, Data Integrity and ALCOA+ Principles

SOP Development for Audit Trail Management

Posted on digi By digi

In clinical research, an audit trail is not just a system feature—it’s a regulatory requirement and a cornerstone of data integrity. Regulatory bodies like the FDA and EMA expect sponsors and CROs to establish Standard Operating Procedures (SOPs) that clearly describe how audit trails are generated, maintained, reviewed, and stored across all systems handling electronic data.

Click to read the full article.

Audit Trails, Data Integrity and ALCOA+ Principles